Yaqrit’s founders are at the front line of treating patients with liver disease and pioneering new research in the field
Professor Rajiv Jalan and a collaborative network of world-class clinicians and scientists are working together to address the unmet need in advanced liver disease
Academic heritage from the labs of UCL
Yaqrit has a deep-rooted academic heritage built on 20 years of pioneering research led by the members of the UCL Liver Failure Group. Scientific founder, Professor Rajiv Jalan is a world-renowned hepatologist with decades of experience in advanced liver disease.
Established by Professor Rajiv Jalan in the labs of UCL
Investments to date to UCL and Yaqrit
Peer reviewed papers published
Worldwide collaboration to seek the answer
We know that partnering and working in collaboration with others are important to accelerate the development of innovative treatment solutions for patients with advanced liver disease.
"Chronic liver disease is a huge global problem. At Yaqrit we are developing a pipeline of breakthrough product candidates designed to address each stage of advanced liver disease, from the clinic to intensive care."
The R&D Engine
The Yaqrit platform integrates technical expertise, clinical trial design and execution with its global collaborator network to accelerate development.
Global network of liver experts
Pioneering liver research and expertise
Close partnership and validation from specialist doctors, grant providers and pharma
Accelerated clinical trial design and execution
Leveraging global influencer network to rapidly initiate and execute trials.
Rigorous regulatory compliance
In house regulatory due diligence expertise, patent and process controls
Proprietary manufacturing capability
Custom built and scalable